Cargando…

Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer

BACKGROUND: Tyrosine metabolism pathway-related genes were related to prostate cancer progression, which may be used as potential prognostic markers. AIMS: To dissect the dysregulation of tyrosine metabolism in prostate cancer and build a prognostic signature based on tyrosine metabolism-related gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Lu, Zhe, Pan, Dongqing, Zhang, Zejian, He, Hua, Wu, Jiacheng, Peng, Naixiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279037/ https://www.ncbi.nlm.nih.gov/pubmed/35847355 http://dx.doi.org/10.1155/2022/5504173

Ejemplares similares

Identification of ISCA1 as novel immunological and prognostic biomarker for bladder cancer
por: Zhou, Renlong, et al.
Publicado: (2022)

Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses
por: Nguyen, Tran N., et al.
Publicado: (2020)

Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells In Vivo and In Vitro
por: Li, Wei, et al.
Publicado: (2021)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Down‐regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR‐212‐5p/FZD5/Wnt/β‐catenin axis
por: Peng, Naixiong, et al.
Publicado: (2021)

Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer
por: Deris Zayeri, Zeinab, et al.
Publicado: (2023)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Reprogramming the metabolism of Synechocystis PCC 6803 by regulating the plastoquinone biosynthesis
por: Fan, Jianhua, et al.
Publicado: (2021)

Effect of PTEN loss on metabolic reprogramming in prostate cancer cells
por: Zhou, Xin, et al.
Publicado: (2019)

Metabolic Reprogramming by Malat1 Depletion in Prostate Cancer
por: Nanni, Simona, et al.
Publicado: (2020)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
por: Claas, Allison M., et al.
Publicado: (2018)

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine
por: Selen Alpergin, Ebru S., et al.
Publicado: (2017)

Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
por: Podrini, Christine, et al.
Publicado: (2018)

Schistosoma japonicum Infection Leads to the Reprogramming of Glucose and Lipid Metabolism in the Colon of Mice
por: Yang, Xiaoying, et al.
Publicado: (2021)

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
por: Sikander, Mohammed, et al.
Publicado: (2019)

SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells
por: de Wet, Larischa, et al.
Publicado: (2022)

Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma
por: Zhou, Renlong, et al.
Publicado: (2022)

The ERK and JNK pathways in the regulation of metabolic reprogramming
por: Papa, Salvatore, et al.
Publicado: (2018)

Nutrition, metabolism, and epigenetics: pathways of circadian reprogramming
por: Sato, Tomoki, et al.
Publicado: (2022)

Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer
por: Yang, Xiao-li, et al.
Publicado: (2022)

Identification of potential diagnostic and prognostic biomarkers for prostate cancer
por: Zhang, Qiang, et al.
Publicado: (2019)

Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline
por: Zheng, Hai-Kuo, et al.
Publicado: (2018)

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
por: Chen, Jing, et al.
Publicado: (2018)

Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
por: Chetta, Paolo, et al.
Publicado: (2021)

Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
por: Chianese, Ugo, et al.
Publicado: (2022)

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
por: Pidsley, Ruth, et al.
Publicado: (2022)

Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
por: Afonso, Julieta, et al.
Publicado: (2023)

Transcriptome sequencing and metabolome analysis reveal the metabolic reprogramming of partial hepatectomy and extended hepatectomy
por: Li, Zeyuan, et al.
Publicado: (2023)

Profiling and quantification of pluripotency reprogramming reveal that WNT pathways and cell morphology have to be reprogramed extensively
por: Hu, Kejin, et al.
Publicado: (2020)

Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism
por: Michalak, Krzysztof Piotr, et al.
Publicado: (2015)

Transcriptional reprogramming of metabolic pathways in critically ill patients
por: Nalos, Marek, et al.
Publicado: (2016)

The role of Wnt signaling pathway in tumor metabolic reprogramming
por: Mo, Yongzhen, et al.
Publicado: (2019)

Tyrosine metabolic reprogramming coordinated with the tricarboxylic acid cycle to drive glioma immune evasion by regulating PD‐L1 expression
por: Wang, Ji‐Yan, et al.
Publicado: (2023)

Metabolic Profiling Reveals Biochemical Pathways and Potential Biomarkers of Spinocerebellar Ataxia 3
por: Yang, Zhi-hua, et al.
Publicado: (2019)

Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
por: Roesler, Rafael, et al.
Publicado: (2021)

URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers
por: Ding, Zhiwen, et al.
Publicado: (2023)

Serum Lipidomic Analysis Reveals Biomarkers and Metabolic Pathways of Thyroid Dysfunction
por: Dong, Hua, et al.
Publicado: (2023)

Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma
por: Cui, Lijuan, et al.
Publicado: (2020)

Nrf2-Mediated Metabolic Reprogramming in Cancer
por: Wang, Yan-Yang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3dpc6ufrgj7hi3bqc2dvej16ia